Rapid detection of nitroaromatic explosives is of utmost importance from the perspectives of civilian safety, the natural environment and human health. Herein, we design a simple yet powerful optical sensing motif based on an electrodeposited luminescent MOF thin film of {[Eu2(TDC)3(CH3OH)2]·CH3OH} (Eu-TDC, where TDC is thiophene-2,5-dicarboxylate). The parameters of the electrodeposition process were investigated and optimized. The phase and elemental composition of the Eu-TDC film were confirmed using powder X-ray diffraction (PXRD) and energy dispersive spectrometry (EDS), and its morphology and structure were examined using scanning electron microscopy (SEM). This thin film shows extremely good luminescence properties with characteristics of Eu(3+) that are sensitized by the electron-rich ligands, which allows for high efficiency in electron-deficient nitroaromatic explosive sensing. Selective and sensitive responses to a series of nitroaromatic explosives were exhibited, especially for nitrophenols (TNP/DNP/4-NP, KSV > 10(4) M(-1)). It is also an efficient luminescent sensor for detecting nitrobenzene vapour. Significantly, this film can be easily recycled just by washing with methanol. The potential sensing mechanisms are discussed in detail.
Repetitive transcranial magnetic stimulation (rTMS) may have the potential to prevent depressive relapse. This assessor-blinded, randomized controlled study was designed to evaluate the efficacy and safety of rTMS as a mono- and combination therapy in the prevention of depressive relapse/recurrence. A total of 281 depressed patients who had achieved stable full or partial remission on a 6-month antidepressant (ADP) run-in treatment were randomly assigned to an rTMS (n = 91), ADP (n = 108), or combined (rTMS + ADP, n = 82) treatment group for 12 months. Monthly clustered rTMS was conducted in 5–10 sessions over a 3–5-day period. Maintenance outcomes were assessed using time to relapse/recurrence and relapse/recurrence rate. Overall, 71.2% (200/281) of the participants completed the treatment per the protocol. rTMS + ADP and rTMS significantly reduced the risk of relapse/recurrence compared with ADP (P = 0.000), with hazard ratios of 0.297 and 0.466, respectively. Both rTMS-containing regimens produced significantly lower relapse/recurrence rates than ADP (15.9% and 24.2% vs. 44.4%, P < 0.001). In the relapsed/recurrent subgroup, first-episode depressed, rTMS-treated patients had a markedly lower relapse/recurrence rate than ADP-treated patients. Five patients on the ADP-containing regimens, but none on rTMS alone, developed acute mania. The rTMS-containing regimens had considerably more certain side effects than did the ADP group. We concluded that TMS, whether as a mono- or additional therapy, is superior to antidepressants in preventing depressive relapse/recurrence, particularly in first-episode depressed patients. The treatment does not increase the risk of manic switch, but may increase the risk of certain side effects.
A Ni supermolecular-networks-coated exfoliated graphene composite is prepared via a facile “two-in-one” electrosynthesis and exhibits excellent supercapacitive performance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.